Clinical Trial Update: A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update describing a Phase 1 open-label, placebo-controlled pharmacokinetic study of GSK1349572 (dolutegravir) assessing its effect on iohexol and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• GSK1349572

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Tuberculosis | Phase 1 | Status: COMPLETED